Home2575 • HKG
add
Xuanzhu Biopharmaceutical Co Ltd
Previous close
$64.50
Day range
$63.95 - $65.00
Year range
$23.82 - $72.00
Avg Volume
652.75K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 8.95M | 11.62% |
Operating expense | 60.01M | 2.52% |
Net income | -55.45M | 0.06% |
Net profit margin | -619.85 | 10.47% |
Earnings per share | — | — |
EBITDA | -51.12M | -9.82% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 109.78M | — |
Total assets | 1.07B | — |
Total liabilities | 220.50M | — |
Total equity | 845.80M | — |
Shares outstanding | 517.95M | — |
Price to book | 34.31 | — |
Return on assets | -13.46% | — |
Return on capital | -16.95% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -55.45M | 0.06% |
Cash from operations | -61.38M | -132.08% |
Cash from investing | -909.00K | 97.05% |
Cash from financing | -1.04M | 27.80% |
Net change in cash | -63.35M | -7.77% |
Free cash flow | -35.88M | — |
About
Founded
2008
Website
Employees
197
